Pictured is one of the many vaccine clinics held on campus during the pandemic.
Photo Credit:
Valerie Hendrickson
Grand Valley will soon enter its third fall semester of the COVID-19
pandemic but the Fall 2022 semester will certainly look different than
two years ago, when students, faculty and staff began repopulating
campus after a stay-at-home executive order.
Since August 2020, more than 25,000 students, faculty and staff
members have received their COVID-19 vaccinations and booster shots
and are considered fully vaccinated.
As GVSU’s pandemic response shifted in response to changing
indicators, so has the work of the Virus Action Team.
VAT, charged with leading the campus through plans established to
keep community members safe, decentralized on April 30. Much of the
work shifted to other departments or dissolved, aligning with similar
actions from local health departments and guidance from the Centers
for Disease Control and Prevention as numbers of positive cases
decreased nationally.
At the height of the pandemic, VAT members met regularly to suggest
policies, and answer emails and phone calls from students, faculty and
staff members. Members of VAT were responsible for the work that led
to a 90 percent campus vaccination rate.
Below is a look at the numbers from Grand Valley's pandemic response:
25,000 Lakers are fully vaccinated, and more than 6,000 reported
at least one booster shot
90% of the campus community is fully vaccinated
2.5 million submissions to the daily self-assessment, with a
96.4% overall pass rate
130,000 free tests were given on campus, with a cumulative
positivity rate of 2.1%
7,511 positive tests by campus members, some were reinfections
15,300 emails sent to VAT
336 regular VAT meetings
Current and past members of VAT are Ed Aboufadel, Dottie Barnes, Tina
Barnikow, Lynn (Chick) Blue, Michele Coffill, Kristi Cooper, Nykia
Gaines, Doug Graham, Kate Harmon, Lisa Haynes, Ben Holder, Dave
Huizen, Jean Nagelkerk, Greg Sanial, Robert Smart and Nykia Gaines.
Two physicians from Spectrum Health with expertise in infectious
diseases served as consultants: Drs. Habiba Hassouna and Russell Lampen.